Cumberland Pharmaceuticals Inc (CPIX) Dividend History

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing, licensing, and commercializing branded prescription products primarily for the hospital, emergency medicine, and specialty care markets. The company is known for its focus on niche therapeutic areas, including acute care and rare diseases, offering products that address unmet medical needs.

2525 West End Avenue, Nashville,, TN, 37203
Phone: 615-255-0068
Website:

Dividend History

Cumberland Pharmaceuticals Inc currently does not pay dividends

Company News

  • The dilated cardiomyopathy market is experiencing steady growth, driven by rising prevalence of heart failure, improved diagnostic techniques, and advancements in genetic testing. Increasing R&D investment in gene therapies and novel drug candidates is expanding treatment options.

    GlobeNewswire Inc.
    Featured Companies: AMGN BMY RCKT SLDB
  • The article discusses the evolving landscape of rare cardiovascular diseases, including Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy. It highlights the challenges in diagnosis and treatment, as well as the growing market size and pipeline of new therapies for these conditions.

    GlobeNewswire Inc.
    Featured Companies: ABBV GOSS INSM JNJ KNSA LQDA MRK TENX THC UTHR
  • Gainers CohBar, Inc. (NASDAQ: CWBR) shares jumped 161% to $4.05 after the company and Morphogenesis announced they have entered into a definitive agreement for an all-stock transaction forming a company combining expertise and resources to advance a late-stage oncology pipeline. HeartCore Enterprises, Inc. (NASDAQ: HTCR) gained 76.6% to $2.26 following better-than-expected first-quarter results. Ocean Biomedical, Inc. (NASDAQ: OCEA) shares climbed 63% to $8.57 after the company announced a patent award for novel cancer immunotherapy treatment, granted for prostate cancer, colon cancer, ovarian cancer, kidney cancer, breast cancer, glioblastoma, melanoma and lung cancer. Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) surged 44% to $1.50 after it was granted U.S. patent #11654157: Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation. Unique Fabricating, Inc. (NYSE: UFAB) climbed 32.8% to $0.2599 after the company announced an accommodation agreement and new forbearance agreement to support a restructuring or sale. Icosavax, Inc. (NASDAQ: ICVX) gained 29.7% to $10.21 after the company announced topline interim Phase 1 results for its bivalent VLP vaccine candidate IVX-A12 against RSV and hMPV in older adults. mCloud Technologies Corp. (NASDAQ: MCLD) jumped 27% to $0.4567 after the company announced it has formed a special committee for the purpose of exploring strategic alternatives. Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) gained 22.6% to $9.96. IMAC Holdings, Inc. (NASDAQ: BACK) climbed 21.9% to $0.1702. Theralink signed definitive merger agreement to be acquired by IMAC Holdings. TuSimple Holdings Inc. (NASDAQ: TSP) climbed 21.2% to $2.01. Lexaria Bioscience Corp. (NASDAQ: LEXX) climbed 20.4% to $0.83. Lexaria Bioscience recently announced it completed its HOR-A22-1 study that showed significant enhancement in the oral delivery of the estrogen hormone estradiol. PacWest Bancorp (NASDAQ: PACW) shares gained 20% to $8.23. PacWest Bancorp shares jumped around 20% on Monday after the company announced it entered into a loan purchase and sale agreement with a subsidiary of Kennedy-Wilson Holdings to sell a portfolio of ...

    Benzinga
  • Gainers Applied UV, Inc. (NASDAQ: AUVI) shares rose 44.6% to $0.69 in pre-market trading after posting better-than-expected quarterly sales. SeqLL Inc. (NASDAQ: SQL) shares surged 34.3% to $0.5377 in pre-market trading after gaining over 19% on Monday. SeqLL recently posted a wider first-quarter loss. HeartCore Enterprises, Inc. (NASDAQ: HTCR) gained 21.1% to $1.55 in pre-market trading following better-than-expected first-quarter results. Bone Biologics Corporation (NASDAQ: BBLG) shares gained 18.8% to $0.1960 in pre-market trading after gaining over 10% on Monday. Movella Holdings Inc. (NASDAQ: MVLA) rose 18.5% to $2.28 in pre-market trading after jumping around 18% on Monday. Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares rose 14.4% to $1.99 in pre-market trading. The FDA recently approved expanded labeling for Cumberland Pharmaceuticals’ Caldolor, an intravenously delivered formulation of ibuprofen, to now include use in infants. Navidea Biopharmaceuticals, Inc. (NASDAQ: NAVB) shares gained 14.1% to $0.1275 in pre-market trading after the company reported the sale of preferred ...

    Benzinga
    Featured Companies: BBLG HTCR MBOT MVST NCPL OESX OMH OTLK PRSO QBTS YELP
  • The Dow Jones settled higher by around 175 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Erasca The Trade: Erasca, Inc. (NASDAQ: ERAS) Director Arthur James Bristol bought a total of 20,000 shares at an average price of $4.14. To acquire these shares, ...

    Benzinga
    Featured Companies: ERAS RCAT
Dividend data last updated 06/06/2025 21:19:38 UTC